New Breast Cancer Study Results Reported from LMU University Hospital (Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer).
In: Women's Health Weekly, 2024-02-06, S. 520-520
serialPeriodical
Zugriff:
A new study on breast cancer has been published by LMU University Hospital in Munich, Germany. The study focused on the use of palbociclib and letrozole in the treatment of advanced breast cancer. The initial report showed a significant improvement in progression-free survival with the combination therapy compared to a placebo. However, the study did not find a significant improvement in overall survival. The researchers noted that the interpretation of the results was limited due to an imbalance in the number of patients with unknown survival outcomes. [Extracted from the article]
Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
New Breast Cancer Study Results Reported from LMU University Hospital (Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer).
|
---|---|
Zeitschrift: | Women's Health Weekly, 2024-02-06, S. 520-520 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1078-7240 (print) |
Sonstiges: |
|